(Q52366312)

30 April 2018

title

Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. (English)

1 reference

30 April 2018

left ventricular hypertrophy

1 reference

1 reference

4

1 reference

30 April 2018

Greg Gamble

2

object named as

Gamble GD

1 reference

30 April 2018

author name string

Greaves SC

1

1 reference

30 April 2018

Collins JF

3

1 reference

30 April 2018

Sharpe DN

5

1 reference

30 April 2018

publication date

1 November 1994

1 reference

30 April 2018

American Journal of Kidney Diseases

published in

1 reference

30 April 2018

volume

24

1 reference

30 April 2018

issue

5

1 reference

30 April 2018

page(s)

768-776

1 reference

30 April 2018

Cardiac abnormalities and exercise tolerance in patients receiving renal replacement therapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Uremic cardiomyopathy: an inadequate left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Left ventricular hypertrophy in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Low-output left ventricular failure in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Predicting survival in adults with end-stage renal disease: an age equivalence index.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

The clinical course of left ventricular hypertrophy in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Regression of left ventricular hypertrophy: partial answers for persistent questions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Echocardiographic-determined left ventricular wall characteristics in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Dialysis-associated ischemic heart disease: insights from coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Cardiovascular changes in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

Echocardiographic assessment of a normal adult aging population

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980670-6

7 January 2021

10.1016/S0272-6386(12)80670-6

Identifiers

DOI

1 reference

30 April 2018

PubMed ID

7977318

1 reference

30 April 2018